The scale of the finding is what makes it remarkable. Proteome diversity has long been acknowledged in principle: heterozygosity in the germline introduces single nucleotide polymorphisms that alter protein sequences, somatic mutations accumulate in tissues over a lifetime, transcriptional errors occasionally corrupt RNA messages, and the ribosome itself is an imperfect machine that misincorporates amino acids at measurable rates. What was missing was a way to detect, quantify, and evaluate the functional consequences of all these variant classes on a proteome-wide scale. The Weizmann team developed exactly that, combining deep mass spectrometry-based proteomics with genomic and transcriptomic data to distinguish variants that are genetically encoded from those that arise through errors during translation, a category the authors call non-genetic substitutions.

The technical challenge is considerable. When a mass spectrometer identifies a peptide whose sequence differs from the reference proteome at a single position, that difference could stem from a germline SNP, a somatic mutation, an RNA editing event, or a mistranslation event in which the ribosome inserted the wrong amino acid. Each explanation carries very different biological implications, and each requires different supporting evidence. By cross-referencing protein-level observations with matched DNA and RNA sequencing from the same tissues, the researchers could partition the 7,215 unique substitutions into their mechanistic classes, confidently localizing each variant to a specific position in a specific protein and assigning it to a genetic or non-genetic origin.

One of the most striking results concerns the abundance of mistranslated proteins. Intuitively, one might expect translational errors to be random noise, with the frequency of any given substitution determined only by the chemical propensities of the misincorporation event. Instead, the team found that the abundance of both genetic variants, such as SNPs and somatic mutations, and mistranslated protein variants mirrors their allele frequencies in the human population. A substitution that is common in the human gene pool tends to appear more abundantly at the protein level, even when it arises through non-genetic means. This unexpected correlation suggests that the translation machinery is tuned, whether by tRNA abundance, codon usage, or amino acid availability, in ways that systematically bias which alternative amino acids appear at which positions, effectively echoing evolutionary statistics in the day-to-day errors of protein synthesis.

This observation leads to the study’s most provocative conceptual claim: non-genetic substitutions may provide a distinct route for exploring protein sequence space, circumventing the mutational constraints imposed by the genetic code. The genetic code restricts which single-nucleotide changes are possible at each codon, and many amino acid pairs are unreachable by any single point mutation. Translational errors are not bound by those rules. A ribosome that misincorporates an amino acid can, in principle, place chemically distant residues at positions that mutation alone could never reach in one step. The proteome, in this view, is not merely a snapshot of the genome but a continuously sampled cloud of sequence variants, some of which may occasionally exhibit useful or biologically meaningful properties without ever being fixed in DNA.

To ensure that the non-genetic variants were not artifacts of the mass spectrometry pipeline, the team went beyond computational analysis and provided experimental validation of non-genetic substitutions on selected purified proteins. Confirming that the substituted proteoforms genuinely exist as intact molecules, rather than as spectral misassignments, is a critical step for a field where false discovery rates in variant peptide identification have historically been a serious concern. The validation anchors the computational survey in biochemical reality and strengthens the case that mistranslation produces stable, detectable protein species in healthy tissue.

The researchers also asked whether non-genetic variation is merely background noise or whether it responds to physiological conditions. In proteome-wide analyses of cancer-derived cell lines subjected to amino acid starvation, they observed specific and recurring non-genetic variation patterns. When cells run short of particular amino acids, the ribosome’s error profile shifts in characteristic ways, producing reproducible substitution patterns across the proteome rather than a random scatter. This condition dependence implies that the landscape of protein variants within a cell is dynamic and environmentally responsive, adding a layer of proteome plasticity that operates entirely below the level of gene expression regulation.

Perhaps most intriguingly, the survey identified hundreds of substituted non-genetic proteoforms that recur consistently in multiple healthy individuals or map to annotated protein functional sites. Recurrence across independent people is difficult to explain by chance, and localization to known functional sites, such as catalytic residues or binding interfaces, raises the possibility that some of these variants carry functional consequences. The authors propose that such substitutions constitute a novel class of functional protein phenotypic variants: sequence changes that arise without any change to the genome, persist as real molecular species, and potentially alter protein behavior. If even a fraction of these variants modulate enzyme activity, binding affinity, or protein stability, the effective functional repertoire of human proteins is substantially larger than annotations based on reference sequences alone would suggest.

The implications ripple outward into several areas of biology and medicine. For personalized medicine, the finding complicates the standard model in which an individual’s disease risk and drug response are read off their genome. If two people with identical genotypes can harbor different repertoires of non-genetic protein variants, shaped by diet, tissue type, and cellular stress, then proteome-level profiling may capture medically relevant information that genomics cannot. For evolutionary biology, the study revives interest in the idea that translation errors could serve as a transient, reversible testing ground for amino acid changes, allowing proteins to probe sequence space before any genetic commitment is made. And for basic biochemistry, the population-level mirroring of mistranslation frequencies hints at deep co-evolution between the genetic code, the translation apparatus, and the amino acid composition of proteins.

Collectively, the findings indicate that non-genetic amino acid substitutions in human proteins provide an abundant and previously underappreciated source of functional proteome expansion. The central dogma remains intact as a description of information flow, but the study shows that the final stage of that flow is far noisier, more structured, and potentially more consequential than the textbook version implies. Every healthy tissue, according to this work, carries thousands of protein variants coexisting with their canonical forms, some genetically encoded and some born of the ribosome’s imperfections, and at least some of them recur predictably across individuals and map onto the very sites where protein function is decided. The human proteome, it turns out, is not a single set of molecules but a population of them, and that population is far larger than the genome alone could ever predict.

Subject of Research: Proteome-wide detection of genetically encoded and non-genetic amino acid substitutions in healthy human tissues

Article Title: Encoded and non-genetic protein variants expand human functional proteome

Article References: Tretyachenko, V., Leiman, T., Morgenstern, D., Levin, Y., Asraf, O., Dahan, O., Dahary, D., & Pilpel, Y. (2026). Encoded and non-genetic protein variants expand human functional proteome. Nature. https://doi.org/10.1038/s41586-026-11124-z

Image Credits: AI Generated

DOI: 10.1038/s41586-026-11124-z

Keywords: proteomics, proteogenomics, mistranslation, protein variants, single amino acid substitutions, central dogma, mass spectrometry, translation errors, functional proteome, human tissues, sequence space, Weizmann Institute